Digoxin is a cardiac glycoside tablet for adults with certain heart rhythm disorders and heart failure. It can help control the heart rate and strengthen cardiac contractions, supporting circulation and symptom relief.
Digoxin is the active substance in Digoxin tablets and belongs to the cardiac glycoside group. Cardiac glycosides increase the force of myocardial contraction while influencing electrical conduction through the heart.
Digoxin is the active substance in Digoxin tablets and belongs to the cardiac glycoside group.
Digoxin has two clinically useful effects. It is a positive inotrope, meaning it makes each heart contraction stronger. It is also a negative chronotrope, meaning it slows the heart rate.
Inside heart cells, digoxin inhibits the sodium-potassium ATPase pump. This increases calcium availability within cardiac muscle cells, allowing a stronger contraction. The effect can improve forward blood flow in selected people with heart failure.
Digoxin also increases vagal activity. The vagus nerve is part of the body’s natural braking system for the heart. Greater vagal influence slows conduction through the atrioventricular node, the electrical gateway between the upper and lower heart chambers. This is why Digoxin can help control the pulse in atrial fibrillation.
| Treatment approach | Main effect | Typical clinical role |
|---|---|---|
| Digoxin | Strengthens contraction and slows AV-node conduction | Rate control in atrial fibrillation, especially with heart failure |
| Beta-blocker therapy | Reduces adrenaline-driven heart-rate increase | Rate control where blood pressure and breathing status allow |
| Rate-limiting calcium-channel blocker therapy | Slows AV-node conduction | Rate control in selected patients without certain forms of heart failure |
Digoxin can be useful when a person has atrial fibrillation alongside reduced heart pumping function. Its limitation is that it often controls resting pulse better than pulse during exertion. Doctors may combine or adjust rate-control treatment where symptoms continue.
Digoxin may be used for:
The medicine does not restore normal rhythm in every person with atrial fibrillation. Its main role is often rate control: it helps prevent the lower chambers of the heart from beating too fast.
Digoxin is a single-ingredient oral cardiac glycoside. Its mechanism differs from treatments that target only symptoms or other aspects of heart rhythm: it increases the force of myocardial contraction while influencing electrical conduction through the heart.
This medicine is not for you if you have ventricular fibrillation, a history of serious sensitivity to digoxin or another cardiac glycoside, or a heart rhythm disorder where Digoxin could worsen conduction without specialist oversight.
Digoxin also needs careful specialist assessment in people with:
Digoxin interacts with medicines that raise its concentration, slow the heart excessively, alter kidney function, or change potassium and magnesium levels. The interaction may be pharmacokinetic, meaning it changes digoxin removal, or pharmacodynamic, meaning both medicines slow cardiac conduction.
Examples requiring active clinical review include:
Digoxin may not be suitable if you have ventricular fibrillation, serious sensitivity to digoxin or another cardiac glycoside, or a heart rhythm problem that could worsen with this medicine. Tell a clinician if you have severe kidney problems, a very slow pulse, heart block, hypertrophic obstructive cardiomyopathy, abnormal potassium, magnesium, or calcium levels, acute myocarditis, or an unstable recent heart attack. Pregnancy and breastfeeding also require an individual medical assessment.
Keep an up-to-date medicines list that includes prescribed tablets, antibiotics, water tablets, antacids, vitamins, and herbal products. Digoxin interactions are often missed when only heart medicines are listed.
Digoxin has a narrow therapeutic range. This means the difference between a helpful blood concentration and an excessive concentration can be small. Toxicity becomes more likely with impaired kidney function, dehydration, low potassium, low magnesium, high calcium, older age, or interacting medicines. [1]
Common unwanted effects can include:
Visual symptoms are a useful clinical clue. Some people describe yellow-green colour changes, bright halos around lights, or unusual blurring. These symptoms do not prove toxicity on their own, yet they should not be ignored when combined with nausea, confusion, or an irregular pulse.
Serious toxicity may cause marked bradycardia, dangerous ventricular arrhythmias, fainting, severe confusion, or collapse. Urgent medical assessment is needed for suspected overdose or significant toxicity symptoms.
Several avoidable errors account for a large share of Digoxin-related problems:
In clinical practice, doctors tend to view Digoxin as a precise medicine rather than a flexible one. A small change in kidney function, hydration, or interacting treatment can turn a previously suitable dose into an excessive one.
For people with atrial fibrillation and heart failure, Digoxin can be a valuable part of rate control. It is not usually chosen for sudden symptom relief. Its benefits develop through steady exposure and regular clinical review.
Digoxin may be continued long term when it remains useful for rate control or heart-failure symptom management. The duration depends on the underlying rhythm disorder, heart function, kidney function, and response to other medicines. NICE guidance published in 2021 places rate control within an individual plan for atrial fibrillation rather than a fixed treatment timetable. A treatment review can lead to continuation, dose adjustment, or a different approach.
Digoxin tablets may be taken with or without food. Taking the tablet at a consistent time can make daily use easier and reduces confusion about missed doses. The FDA prescribing information revised in 2024 describes oral digoxin use and emphasises individual dose selection. High-fibre products or certain antacids may affect absorption when taken close together, so timing may need adjustment.
Do not take two doses together. The appropriate response depends on the prescribed schedule and how much time has passed, because Digoxin has a narrow therapeutic range. NHS medicines guidance reviewed in 2023 advises against double dosing after a missed tablet. A prescriber can provide a personal missed-dose plan for people with complex regimens.
Digoxin toxicity can cause visual changes. Blurred vision, colour changes, and halos around lights can occur with excessive digoxin effect, especially when combined with nausea, confusion, weakness, or a slow pulse. The British Journal of Cardiology discussed visual disturbance as a recognised feature of digoxin toxicity in its 2024 review. New visual symptoms should be assessed promptly rather than attributed automatically to eye strain.
The kidneys remove a large proportion of digoxin from the body. When kidney function falls, the medicine can accumulate and increase the risk of bradycardia, confusion, gastrointestinal symptoms, and arrhythmias. MHRA medicines information published in 2023 identifies renal function as a key factor in digoxin dose selection and monitoring. Blood tests also assess potassium and magnesium because electrolyte imbalance can increase toxicity risk.
Stopping Digoxin without a clinical plan can allow the heart rate to rise again or heart-failure symptoms to worsen. The decision depends on why it was prescribed, what other medicines are being used, and the person’s ECG and symptom pattern. NICE chronic heart failure guidance from 2018 supports regular review of medicines rather than unsupervised withdrawal. A clinician may reduce, replace, or continue therapy after reviewing the whole cardiac treatment plan.
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
